Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
104.920,53
0,06%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Royalty Pharma PLC (RPRX) Royalty Pharma PLC (RPRX) Notizie

Royalty Pharma PLC

RPRX
31,06
0,44 (1,44%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/1/202523:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/1/202523:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/1/202523:04EDGAR2Form 425 - Prospectuses and communications, business..
13/1/202514:42EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/1/202514:40EDGAR2Form 8-K - Current report
10/1/202523:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/1/202523:21EDGAR2Form 8-K - Current report
10/1/202513:47EDGAR2Form 8-K - Current report
10/1/202513:30GLOBERoyalty Pharma to Highlight Accomplishments and Provide..
10/1/202513:15GLOBERoyalty Pharma Announces Transformative Step in Company’s..
09/1/202522:15GLOBERoyalty Pharma Announces Dividend Increase
31/12/202422:05EDGAR2Form 8-K - Current report
27/11/202422:15GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
14/11/202422:30GLOBERoyalty Pharma Announces Inaugural Prize for Impact in..
07/11/202413:10GLOBERoyalty Pharma to Acquire Royalty Interest in Geron’s RYTELO..
06/11/202415:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:35EDGAR2Form 8-K - Current report
06/11/202413:15GLOBERoyalty Pharma Reports Third Quarter 2024 Results
04/11/202422:15GLOBERoyalty Pharma and Syndax Pharmaceuticals Enter Into $350..
04/11/202422:01PRNUSSyndax Pharmaceuticals and Royalty Pharma Enter into $350..
16/10/202422:15GLOBERoyalty Pharma to Announce Third Quarter 2024 Financial..
11/10/202414:15GLOBERoyalty Pharma Declares Fourth Quarter 2024 Dividend
27/9/202414:39EDGAR2Form 8-K - Current report
03/9/202423:14GLOBERoyalty Pharma and Ascendis Pharma Enter Into $150 Million..
03/9/202423:06GLOBEAscendis Pharma and Royalty Pharma Enter into $150 Million..
28/8/202422:15GLOBERoyalty Pharma to Present at Morgan Stanley’s 22nd Annual..
13/8/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202415:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:20EDGAR2Form 8-K - Current report
08/8/202413:00GLOBERoyalty Pharma Reports Second Quarter 2024 Results
07/8/202413:04EDGAR2Form 8-K - Current report
29/7/202422:30EDGAR2Form SC 13D/A - General Statement of Acquisition of..
24/7/202414:30GLOBERoyalty Pharma Appoints Molly Sawaya as Executive Vice..
19/7/202414:15GLOBERoyalty Pharma to Announce Second Quarter 2024 Financial..
17/7/202422:15GLOBERoyalty Pharma Declares Third Quarter 2024 Dividend
20/6/202414:03EDGAR2Form 8-K - Current report
10/6/202422:58EDGAR2Form 8-K - Current report
06/6/202423:06EDGAR2Form 8-K - Current report
04/6/202423:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/6/202422:57EDGAR2Form 8-K - Current report
04/6/202422:15GLOBERoyalty Pharma to Present at the Goldman Sachs 45th Annual..
03/6/202423:15GLOBERoyalty Pharma Announces Pricing of $1.5 Billion of Senior..
03/6/202422:59EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
03/6/202415:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/6/202414:39EDGAR2Form S-3ASR - Automatic shelf registration statement of..
29/5/202423:25EDGAR2Form 8-K - Current report
28/5/202413:10GLOBERoyalty Pharma and Agios Pharmaceuticals Enter Into..
22/5/202422:10GLOBERoyalty Pharma and Cytokinetics Announce Expanded Strategic..
Apertura: 30,61 Min: 30,61 Max: 31,10
Chiusura: 30,62

La tua Cronologia

NASDAQ
RPRX
Royalty Pharma
TG
3RT
Resideo Technologies
NYSE
NUV
Nuveen Muni Value
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network